Harmonization of Quantitative Values in Bone SPECT/CT for Medication-Related Osteonecrosis of the Jaw
- Issei Kuromori 1, Hiromitsu Daisaki 2, Yoshiki Owaki 3, Tatsuya Tsuchitani 4, Naoya Hayashi 5, Masakazu Tsujimoto 6, Yukito Maeda 7, Naomi Ueno 8, Yu Iwabuchi 3, Takashi Norikane 7, Yoshitaka Inui 6, Hayato Kaida 9, Kimiteru Ito 10, Kazuhiro Kitajima 11
- 1Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, Maebashi, Japan.
- 2Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, Maebashi, Japan; daisaki@gchs.ac.jp.
- 3Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
- 4Department of Radiological Technology, Hyogo College of Medicine College Hospital, Hyogo, Japan.
- 5Department of Medical Technology, Kochi Medical School Hospital, Kochi, Japan.
- 6Department of Radiology, Fujita Health University Hospital, Toyoake, Japan.
- 7Department of Radiology, Kagawa University Hospital, Kagawa, Japan.
- 8Radiology Center, Kindai University Hospital, Osaka, Japan.
- 9Department of Radiology, Faculty of Medicine, Kindai University, Osaka, Japan.
- 10Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan; and.
- 11Department of Radiology, Hyogo Medical University, Hyogo, Japan.
- 0Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, Maebashi, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Harmonizing quantitative SPECT/CT (Q-SPECT/CT) improves medication-related osteonecrosis of the jaw (MRONJ) diagnosis. A software-based approach reduces scanner variability, enabling reliable multicenter studies for MRONJ detection.
Area Of Science
- Nuclear Medicine
- Medical Imaging
- Oncology
Background
- Medication-related osteonecrosis of the jaw (MRONJ) significantly impacts patient quality of life.
- Accurate MRONJ diagnosis is crucial due to increased use of antiresorptive and antiangiogenic agents.
- Quantitative SPECT/CT (Q-SPECT/CT) shows promise for MRONJ detection, but inter-scanner variability hinders multicenter research.
Purpose Of The Study
- To establish harmonization criteria for Q-SPECT/CT in MRONJ diagnosis.
- To evaluate a software-based approach for harmonizing Q-SPECT/CT data across different scanners.
- To reduce inter-scanner variability in quantitative measurements for multicenter MRONJ studies.
Main Methods
- A multicenter phantom study using a custom brain tumor phantom with 6 hot spheres and <sup>99m</sup>Tc-hydroxymethylene diphosphonate.
- SPECT/CT imaging performed at 7 institutions on 8 scanners following clinical protocols.
- Software-based analysis for SUV conversion, region of interest analysis, and harmonization using a median SUV<sub>max</sub> ± 30% criterion with Gaussian filtering.
Main Results
- Background SUV<sub>mean</sub> remained consistent (0.95-1.05) before and after harmonization, showing minimal interscanner differences.
- Inter-scanner variability for hot spheres significantly improved: SUV<sub>max</sub> coefficient of variation reduced from 122% to 48%, SUV<sub>peak</sub> from 68% to 35%, and SUV<sub>mean</sub> from 71% to 37%.
- The software-based harmonization effectively reduced variability without compromising image quality or requiring additional reconstruction.
Conclusions
- A novel harmonization criterion for Q-SPECT/CT in MRONJ was identified.
- The software-based harmonization approach successfully reduces inter-scanner variability in Q-SPECT/CT for MRONJ.
- This method supports the feasibility and reliability of multicenter clinical studies for MRONJ detection and staging.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

